Paragraph IV Certifications: How Generic Drug Makers Challenge Patents Before Launch
Paragraph IV certifications let generic drug makers challenge brand-name patents before launch, speeding up access to cheaper medications. This legal tool under the Hatch-Waxman Act has saved U.S. consumers trillions and reshaped the pharmaceutical market.
Read More